Sai Parenterals Q4 FY 26 Results: PAT Rises 45.5% to ₹14.37 Crore
Strong FY26 Growth for Sai Parenterals Pharmaceutical company Sai Parenterals delivered a strong financial performance in FY26, reporting a 45.52 percent year-on-year rise in profit after tax (PAT)…